Danazol has been associated with several cases of benign intracranial hypertension also known as pseudotumor cerebri.
Talk to your doctor about the risks of taking danazol.
Danazol can decrease hepatic synthesis of procoagulant factors, increasing the possibility of bleeding when used concurrently with thrombolytic agents.
As a result of this action the serum levels of the C4 component of the complement system are also increased. Modest increase in serum transaminase levels and rarely cholestatic jaundice, benign hepatic adenomata and pancreatitis. A direct effect on steroid receptor sites in breast tissue is also possible. Reversible erythrocytosis or polycythaemia may be provoked. Consult the product labeling for statin drugs for specific information on dose restrictions in presence of danazol.
Talk to your doctor about the risks of taking danazol. In women of childbearing age, this medication should be started during their menstrual period.
Ask your doctor before use if you are taking the following medications:
Experience with thiamphenicol is insufficient to analyze a risk in pregnancy.
The most common risk factor for the development of atrial fibrillation is hypertension, 1 and two common complications in atrial fibrillation are stroke and heart failure, both of which are related to elevated blood pressure.
Using the two medications together, you are tackling blood pressure issues in two different ways, which increases the ability of lowering your blood pressure numbers, more than by using one medication alone.
To reduce the risk of seizures, your doctor may increase your dosage slowly.
Danazol not only prevents telomere loss, but a mean increase occurs with improvement observed early during the course of hormone therapy. The growth of endometriotic tissue is under hormonal influence, and danazol is used to control the fluctuations in hormone levels that stimulate the growth of this tissue. In general, low testosterone concentrations are associated with insulin resistance, and may worsen hyperglycemia.